December 1, 2023

Novo alleges potency discrepancy, impurities in compounded semaglutide

We’ll let you read it for yourself. Interesting how the reporter seems to take Novo’s word for it, no? 

(This is a late-breaking story. APC and its attorneys are reviewing and may issue a statement.)